A previous compound screen identified two molecules with histone deacetylase 6 (HDAC6) inhibitory activity that reduced Alzheimer's disease (AD)-like tau inclusions in a primary rat cortical neuron model seeded with AD brain-derived tau fibrils. The gene discussed is MAPT; the disease is Alzheimer disease.